GIOMMONI, ELISA
 Distribuzione geografica
Continente #
EU - Europa 2.353
NA - Nord America 2.332
AS - Asia 1.551
SA - Sud America 132
Continente sconosciuto - Info sul continente non disponibili 66
AF - Africa 37
OC - Oceania 20
Totale 6.491
Nazione #
US - Stati Uniti d'America 2.264
IT - Italia 643
RU - Federazione Russa 582
PL - Polonia 577
CN - Cina 454
SG - Singapore 400
HK - Hong Kong 190
IE - Irlanda 142
VN - Vietnam 139
KR - Corea 128
BR - Brasile 102
FI - Finlandia 70
IN - India 65
SE - Svezia 64
FR - Francia 60
DE - Germania 57
AT - Austria 40
CA - Canada 39
BD - Bangladesh 38
JO - Giordania 38
ID - Indonesia 34
GB - Regno Unito 33
NL - Olanda 25
AU - Australia 20
CH - Svizzera 20
JP - Giappone 20
MX - Messico 18
ES - Italia 10
ZA - Sudafrica 10
IQ - Iraq 9
AR - Argentina 8
MA - Marocco 7
UA - Ucraina 7
NG - Nigeria 6
PK - Pakistan 6
VE - Venezuela 6
CL - Cile 5
CZ - Repubblica Ceca 4
EG - Egitto 4
MY - Malesia 4
SA - Arabia Saudita 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
BE - Belgio 3
CO - Colombia 3
EC - Ecuador 3
LT - Lituania 3
TR - Turchia 3
CI - Costa d'Avorio 2
ET - Etiopia 2
LV - Lettonia 2
NO - Norvegia 2
PA - Panama 2
PE - Perù 2
PH - Filippine 2
PY - Paraguay 2
SK - Slovacchia (Repubblica Slovacca) 2
TW - Taiwan 2
AZ - Azerbaigian 1
BB - Barbados 1
BJ - Benin 1
BO - Bolivia 1
BZ - Belize 1
CR - Costa Rica 1
CU - Cuba 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GE - Georgia 1
GH - Ghana 1
GP - Guadalupe 1
GT - Guatemala 1
IL - Israele 1
KE - Kenya 1
KH - Cambogia 1
KZ - Kazakistan 1
MD - Moldavia 1
OM - Oman 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
RS - Serbia 1
SN - Senegal 1
TG - Togo 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
Totale 6.425
Città #
Warsaw 576
Santa Clara 518
Ashburn 407
Singapore 273
Hong Kong 170
Hefei 151
Dublin 136
Seoul 128
San Jose 120
Florence 95
Milan 90
Fairfield 88
Council Bluffs 75
Chandler 63
Beijing 54
Los Angeles 51
Seattle 46
Rome 41
Helsinki 40
Vienna 39
New York 37
Woodbridge 37
Ho Chi Minh City 36
Wilmington 35
Cambridge 34
Houston 34
Munich 34
Lauterbourg 32
Buffalo 31
Dallas 31
Jakarta 31
Hanoi 29
Moscow 29
Boston 24
Paris 24
Boardman 22
Lawrence 22
Shanghai 22
Altamura 21
Pune 20
Kent 19
Mumbai 19
Melbourne 18
Bern 16
Dong Ket 16
The Dalles 16
Tokyo 16
Turku 16
Princeton 15
London 13
Toronto 13
Turin 12
Bengaluru 11
São Paulo 11
Naples 10
Orem 9
Ann Arbor 8
Atlanta 8
Brescia 8
Chicago 8
Lappeenranta 8
Montesilvano Marina 8
Montreal 8
Phoenix 8
West Jordan 8
Amsterdam 7
Figino 7
Frankfurt am Main 7
Genoa 7
Johannesburg 7
Medford 7
North Charleston 7
Bremen 6
Dearborn 6
Haiphong 6
Redondo Beach 6
San Diego 6
Shenzhen 6
Tianjin 6
Abuja 5
Bari 5
Belo Horizonte 5
Brasília 5
Brooklyn 5
Catania 5
Charlotte 5
Cinisello Balsamo 5
Mexico City 5
Mosier 5
Palermo 5
San Francisco 5
Treviso 5
Amandola 4
Barnet 4
Biên Hòa 4
Bologna 4
Cagliari 4
Chennai 4
Clifton 4
Falls Church 4
Totale 4.236
Nome #
Oxaliplatin, 5-fluorouracil/leucovorin and epirubicin as first-line treatment in advanced gastric carcinoma: A phase II study 348
hERG1 Channels Regulate VEGF-A Secretion in Human Gastric Cancer: Clinicopathological Correlations and Therapeutical Implications 347
VEGF-A clinical significance in gastric cancers: immunohistochemical analysis of a wide Italian cohort. 302
Gallbladder neuroendocrine neoplasm: a case report and critical evaluation of WHO classification 282
HER2 loss in HER2-positive gastric or gastroesophageal cancer after trastuzumab therapy: Implication for further clinical research 258
Evaluation of Fruquintinib in the Continuum of Care of Patients with Colorectal Cancer 251
Osteonecrosis of the Jaw and Angiogenesis inhibitors: A Revival of a Rare but Serous Side Effect 232
Aflibercept plus folfiri as second-line treatment for metastatic colorectal cancer: A single-institution real-life experience 232
Absolute eosinophil count predicts clinical outcomes and toxicity in non-small cell lung cancer patients treated with immunotherapy 209
The role of nanoliposomal irinotecan plus fluorouracil/leucovorin in the continuum of care of patients with metastatic pancreatic ductal adenocarcinoma 205
Update on gastric cancer treatments and gene therapies 204
Association of systemic steroid treatment and outcome in patients treated with immune checkpoint inhibitors: A real-world analysis 203
Bevacizumab plus XELOX as first-line treatment of metastatic colorectal cancer: The OBELIX study 199
Circulating tumour cells and cell-free DNA as a prognostic factor in metastatic colorectal cancer: the OMITERC prospective study 193
Eosinophil Count as Predictive Biomarker of Immune-Related Adverse Events (irAEs) in Immune Checkpoint Inhibitors (ICIs) Therapies in Oncological Patients 187
Somatostatin analogs in pregnant patients with neuroendocrine tumor 187
Immune-related adverse events in oncological patients treated with immune checkpoint inhibitors 187
Results of the observational prospective RealFLOT study 183
Perioperative Tailored Treatments for Gastric Cancer: Times Are Changing 183
Isoforms of the orphan nuclear receptor COUP-TFII differentially modulate pancreatic cancer progression 182
Systemic Sclerosis Association with Malignancy 177
hERG1 Channels and Glut-1 as Independent Prognostic Indicators of Worse Outcome in Stage I and II Colorectal Cancer: A Pilot Study. 176
Editorial: Redox Potential and Metabolic Behavior in Gastrointestinal Cancers 172
Prognostic role of sodium levels in colorectal cancer patients receiving aflibercept plus FOLFIRI 168
Association between Immune Related Adverse Events and Outcome in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors 167
Activity and Safety of NAB-FOLFIRI and NAB-FOLFOX as First-Line Treatment for metastatic Pancreatic Cancer (NabucCO Study) 162
Regorafenib also can cause osteonecrosis of the jaw 155
Optimizing First-Line Chemotherapy in Metastatic Pancreatic Cancer: Efficacy of FOLFIRINOX versus Nab-Paclitaxel Plus Gemcitabine 129
Response 128
Guideline Application in Real world: multi-Institutional Based survey of Adjuvant and first-Line pancreatic Ductal adenocarcinoma treatment in Italy. Primary analysis of the GARIBALDI survey 125
Everolimus as maintenance therapy in advanced neuroendocrine neoplasms: Results from the MAVERIC Phase II Trial (1499 WORDS MAIN TEXT) 122
Treatment Strategy for Oligometastatic Gastric Cancer: Brief Considerations 95
Perioperative Tailored Treatments for Gastric Cancer: Times Are Changing 94
Immune checkpoint inhibitors in the first-line treatment of esophageal squamous cell carcinoma: Minireview for a big shift 47
Totale 6.491
Categoria #
all - tutte 19.727
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.727


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022112 0 2 5 3 4 1 4 17 11 8 26 31
2022/2023490 23 70 17 24 36 97 67 40 61 14 19 22
2023/2024445 8 29 33 17 30 73 26 80 11 42 46 50
2024/20251.828 48 161 103 271 456 253 41 115 80 59 105 136
2025/20262.495 300 325 278 226 255 74 258 127 153 158 86 255
2026/2027182 114 68 0 0 0 0 0 0 0 0 0 0
Totale 6.491